Publications by authors named "Doug Marcotte"

Claim this Profile
A
ATP-Competitive MLKL Binders Have No Functional Impact on Necroptosis.
Bin Ma, Doug Marcotte, Murugan Paramasivam, Klaus Michelsen, Ti Wang

PLoS One· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-based design of low-nanomolar PIM kinase inhibitors.
Alexey Ishchenko, Lin Zhang, Jean-Yves Le Brazidec, Junhua Fan, Jer Hong Chong, Doug Marcotte

Bioorg Med Chem Lett· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enabling structure-based drug design of Tyk2 through co-crystallization with a stabilizing aminoindazole inhibitor.
Maria A Argiriadi, Eric R Goedken, David Banach, David W Borhani, Andrew Burchat, Doug Marcotte

BMC Struct Biol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, and biological evaluation of pyrazolopyrimidine-sulfonamides as potent multiple-mitotic kinase (MMK) inhibitors (part I).
Lin Zhang, Junhua Fan, Jer-Hong Chong, Angela Cesena, Betty Y Y Tam, Doug Marcotte

Bioorg Med Chem Lett· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and characterization of non-ATP site inhibitors of the mitogen activated protein (MAP) kinases.
Kenneth M Comess, Chaohong Sun, Cele Abad-Zapatero, Eric R Goedken, Rebecca J Gum, Doug Marcotte

ACS Chem Biol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis